Phibro Animal Health (PAHC) Capital Expenditures (2013 - 2026)

Phibro Animal Health's Capital Expenditures history runs 14 years deep, the most recent figure standing at -$25.6 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 431.11% year-over-year to -$25.6 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 67.57% decrease from a year earlier, with the FY2025 full-year figure at $38.3 million, down 7.14% from the prior year.
• Capital Expenditures retreated to -$25.6 million in Q1 2026 per PAHC's latest filing, from $24.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $41.9 million in Q1 2023 and bottomed at -$25.6 million in Q1 2026.
• The 5-year median for Capital Expenditures is $9.7 million (2024), against an average of $7.0 million.
• Across the five-year window, Capital Expenditures jumped 4917.28% in 2024 and sank 431.11% in 2026, its largest moves.
• Year by year, Capital Expenditures stood at -$24.2 million in 2022, then jumped by 175.35% to $18.2 million in 2023, then sank by 57.13% to $7.8 million in 2024, then surged by 217.03% to $24.8 million in 2025, then slumped by 203.43% to -$25.6 million in 2026.
• Per Business Quant, the three latest PAHC Capital Expenditures figures stand at -$25.6 million (Q1 2026), $24.8 million (Q4 2025), and $105000.0 (Q3 2025).